Visualizing viral replication of oncogenic human herpesviruses

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor, Biological and Biomedical Sciences, North Carolina Central University
    Biography

      Dr. Costantini completed her doctorate degree in Biomedical Research at Albert Einstein College of Medicine in New York. Dr. Costantini’s research focus integrates her background in cellular and molecular biology and virology with high-resolution microscopy approaches. At North Carolina Central University, Dr. Costantini’s research lab studies the replication and lifecycle of human herpesvirus, Kaposi’s Sarcoma Herpesvirus. More specifically, the viral DNA replication machinery and the factors that may influence viral replication.


    Abstract

    Viruses are the causative agents of approximately 12% of human cancers. The most recently discovered herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV) is known to cause three human cancers. Effective antiviral therapeutics are needed for the treatment of KSHV. Viral DNA replication and the KSHV DNA replication proteins are essential to successful viral replication and, thus, appealing therapeutic targets. Our focus is characterizing the functions and molecular interactions of the core KSHV DNA replication proteins in order to develop potential therapeutic strategies against KSHV infection. Herpesviruses encode their own DNA replication machinery. KSHV expresses six DNA replication proteins: DNA polymerase (ORF9), polymerase accessory factor (ORF59), helicase (ORF44), primase (ORF56), primase associated factor (ORF40/41), and single-stranded DNA binding protein (ORF6). The binding of the KSHV polymerase processivity factor, ORF59 (PF-8), to the viral polymerase, ORF9 (Pol-8) promotes continual synthesis of DNA. We visualized ORF59 using negative staining with electron microscopy. We predict head to tail dimers assemble into higher order oligomeric rings composed of four or six monomers, which may function as a sliding clamp during DNA replication. To investigate ORF50 binding in the context of viral DNA replication, we performed in vitro binding assays with purified ORF50 and isolated lytic origin DNA. We visualized purified ORF50 binding to the 2.4kB lytic origin of replication (OriLyt-R) using tungsten metal shadow casting with electron microscopy. We mapped ORF50 binding to OriLyt-R to three distinct regions. Two regions represent novel binding locations. We measured the average area of origin bound ORF50. We predict ORF50 dimerization may stabilize protein-DNA interaction as well as facilitate the binding of additional KSHV DNA replication proteins. Our preliminary finding provides novel insights into the activities of KSHV proteins. Our in-depth molecular study of the core DNA replication proteins will advance the general understanding of KSHV biology.

    Learning Objectives:

    1. Define the phases of herpesvirus infection

    2. Explain high resolution electron microscopy-based approaches to study protein-protein and protein-DNA interactions

    3. Identify novel activities of KSHV DNA viral replication proteins.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources